ArticleWorld journal of gastroenterology2001
Expression of insulin like growth factor II and its receptor in hepatocellular carcinogenesis.
Article in World journal of gastroenterology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 24 citations in OpenAlex.
- Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma.World journal of gastroenterology · 2008Review
- Molecular Pathogenesis of Hepatitis-B-virus-associated Hepatocellular Carcinoma.Gut and liver · 2007Article
- Chronic hepatitis B in hepatocarcinogenesis.Postgraduate medical journal · 2006Review
- Clinical significance of serum IGF-I, IGF-II and IGFBP-3 in liver cirrhosis.World journal of gastroenterology · 2004Article
- Expression of IGF-II in early experimental hepatocellular carcinomas and its significance in early diagnosis.World journal of gastroenterology · 2003Article
- Potent inhibition of angiogenesis and liver tumor growth by administration of an aerosol containing a transferrin-liposome-endostatin complex.World journal of gastroenterology · 2003Article
- Expression of p53 and C-myc genes and its clinical relevance in the hepatocellular carcinomatous and pericarcinomatous tissues.World journal of gastroenterology · 2002Article
- Preparation of monoclonal antibody against apoptosis-associated antigens of hepatoma cells by subtractive immunization.World journal of gastroenterology · 2002Article
- P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection.World journal of gastroenterology · 2002Article
- Inhibitory effect of endostatin expressed by human liver carcinoma SMMC7721 on endothelial cell proliferation in vitro.World journal of gastroenterology · 2002Article
- Transcription factor EGR-1 inhibits growth of hepatocellular carcinoma and esophageal carcinoma cell lines.World journal of gastroenterology · 2002Article
- Expression and bioactivity identification of soluble MG7 scFv.World journal of gastroenterology · 2002Article
- Expression of liver cancer associated gene HCCA3.World journal of gastroenterology · 2001Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.